NCT03942757View on ClinicalTrials.gov

BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Preterm InfantJaundice, NeonatalPhototherapy
Interventions
OTHER

bilirubin serum level determination

bilirubin serum level before and after phototherapy treatment will be measured

OTHER

Phototherapy

Preterm infant \< 35 weeks of gestation with a jaundice requiring phototherapy according to NICE guidelines can be included for the duration of the phototherapy treatment.

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03942757 - BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator | Biotech Hunter | Biotech Hunter